Kura Oncology earnings were -$174.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest KURA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$19.2M, down 64.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KURA reported annual earnings of -$174.0M, with 14% growth.
On KURA's earnings call on Invalid Date, Kura Oncology (NASDAQ: KURA) reported Q4 2024 earnings per share (EPS) of -$0.22, up 60% year over year. Total KURA earnings for the quarter were -$19.22 million. In the same quarter last year, Kura Oncology's earnings per share (EPS) was -$0.55.
As of the last Kura Oncology earnings report, Kura Oncology is currently losing money. Kura Oncology's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$173.98 million, a 13.99% increase year over year.
What was KURA's earnings growth in the past year?
As of Kura Oncology's earnings date in Invalid Date, Kura Oncology's earnings has grown year over year. KURA earnings in the past year totalled -$173.98 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.